Fatigue News and Research

RSS

Workers report higher level of fatigue from the use of videoconferencing apps during the pandemic

Researchers at Nanyang Technological University, Singapore (NTU Singapore) have found that the increased use of videoconferencing platforms during the COVID-19 pandemic contributed to a higher level of fatigue, as reported by workers.

15 Jul 2022

Evidence for a specific anti-inflammatory metabolic signature in long-COVID

A recent research paper posted to the medRxiv* preprint server illustrated anti-inflammatory and hypo-metabolic fingerprints in long coronavirus disease (COVID) syndrome (LCS) using pan-omics plasma assessments.

15 Jul 2022

Study: Three quarters of elite football players battled fatigue for six weeks after COVID-19

Matchday performance of professional footballers dropped after recovering from COVID-19 with three quarters fighting fatigue for six weeks, a University of Essex study has found.

14 Jul 2022

Video game intervention improves attention and executive functioning in patients with lupus

A National Jewish Health led study recently published in Lupus finds that technology through video game-based cognitive therapy improves attention and executive functioning in patients with systemic lupus erythematosus (SLE).

14 Jul 2022

Antibody signatures strongly associated with SARS-CoV-2 immunopathology identified using a novel B cell epitope discovery method

A recent study discovered antibody footprints strongly correlated with immunopathology of SARS-CoV-2 infection using a new B cell epitope identification approach

14 Jul 2022

The disease burden and clinical severity of the SARS-CoV-2 Omicron BA.2 sublineage outbreak in Shanghai

Researchers estimated the severity and burden of COVID-19 in a recent outbreak in Shanghai, China.

14 Jul 2022

Few people may have symptoms of depression years before their stroke, finds study

While depression is a common problem for people who have had a stroke, some people may have symptoms of depression years before their stroke, according to a study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Jul 2022

People with non-alcoholic fatty liver disease may have higher risk of dementia

People who have non-alcoholic fatty liver disease, a buildup of fat cells in the liver, may have a higher risk of dementia, according to a new study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Jul 2022

What are the biological features, prevention and control strategies against monkeypox?

Researchers elucidated the epidemiology and clinical presentation, biological features, pathogenicity and prevention and control strategies for monkeypox virus (MPXV) infections.

13 Jul 2022

Study highlights the psychological adjustment of health-care volunteers during COVID-19 pandemic

Many medical professionals who volunteered for short-term deployment to a field hospital in New York during the COVID-19 pandemic experienced high levels of secondary traumatic stress, a new study found.

13 Jul 2022

Long covid patients travel abroad seeking for unproven "blood-washing" treatment

Thousands of people experiencing the debilitating symptoms of long covid are traveling abroad to seek costly but unproven treatments such as "blood washing", according to an investigation carried out by The BMJ and ITV News released today.

13 Jul 2022

How do symptom burden and viral kinetics differ between healthy, vaccinated adults infected with either Delta, Omicron BA.1, or BA.2?

Researchers assessed the symptom profiles present in SARS-CoV-2 Delta, Omicron BA1. and BA.2-infected patients.

12 Jul 2022

Clinical presentation of monkeypox infection in two Israeli males

Researchers described the symptomatology and clinical manifestations of monkeypox infections among two Israeli patients.

12 Jul 2022

Comparison of complaints following second and third COVID mRNA vaccine doses

In a recent article posted to the medRxiv* preprint server, investigators in Norway and Sweden compared medical complaints after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection following second and third dose SARS-CoV-2 vaccinations.

12 Jul 2022

CDC posts investigation notice about multistate outbreak of Listeria infections

A CDC Investigation Notice regarding a multistate outbreak of Listeria infections has been posted: Listeria Outbreak | CDC.Listeria Outbreak | CDC

10 Jul 2022

Researchers discover the first effective drug to treat rare, genetic liver disease

Researchers at Saint Louis University's School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly could only be treated with a liver transplant.

8 Jul 2022

Researchers analyze acute and post-acute COVID-19 presentations in athletes

Researchers at the University of São Paulo (USP) in Brazil analyzed data from 43 scientific articles describing the effects of COVID-19 on athletes and concluded that while the disease was asymptomatic or mild in the vast majority of cases (94%), about 8% of the subjects concerned had persistent symptoms affecting their performance and potentially preventing a return to training and competing.

8 Jul 2022

Clinical trial examining the combination of atezolizumab and chemoradiation for patients with limited-stage SCLC reaches accrual

The NRG Oncology/Alliance clinical trial NRG-LU005, examining the addition of the immunotherapy drug atezolizumab combined with chemoradiation for patients with limited-stage small cell lung cancer (SCLC) recently reached the trial's accrual goal of 506 patients.

8 Jul 2022

High prevalence of persistent cardiovascular symptoms in COVID-19 recovered patients according to new study

Scientists recently conducted a study on community-dwelling adults to determine the prevalence and risk factors of long-term cardiovascular symptoms in COVID-19 recovered individuals.

8 Jul 2022

Immunogenicity and safety of the protein-based heterodimer booster vaccine for COVID-19

Researchers compared the immunogenicity and safety of the protein-based heterodimer vaccine (PHH-1V) and BNT162b2 COVID-19 vaccines.

8 Jul 2022

Fatigue News and Research

Workers report higher level of fatigue from the use of videoconferencing apps during the pandemic

Evidence for a specific anti-inflammatory metabolic signature in long-COVID

Study: Three quarters of elite football players battled fatigue for six weeks after COVID-19

Video game intervention improves attention and executive functioning in patients with lupus

Antibody signatures strongly associated with SARS-CoV-2 immunopathology identified using a novel B cell epitope discovery method

The disease burden and clinical severity of the SARS-CoV-2 Omicron BA.2 sublineage outbreak in Shanghai

Few people may have symptoms of depression years before their stroke, finds study

People with non-alcoholic fatty liver disease may have higher risk of dementia

What are the biological features, prevention and control strategies against monkeypox?

Study highlights the psychological adjustment of health-care volunteers during COVID-19 pandemic

Long covid patients travel abroad seeking for unproven "blood-washing" treatment

How do symptom burden and viral kinetics differ between healthy, vaccinated adults infected with either Delta, Omicron BA.1, or BA.2?

Clinical presentation of monkeypox infection in two Israeli males

Comparison of complaints following second and third COVID mRNA vaccine doses

CDC posts investigation notice about multistate outbreak of Listeria infections

Researchers discover the first effective drug to treat rare, genetic liver disease

Researchers analyze acute and post-acute COVID-19 presentations in athletes

Clinical trial examining the combination of atezolizumab and chemoradiation for patients with limited-stage SCLC reaches accrual

High prevalence of persistent cardiovascular symptoms in COVID-19 recovered patients according to new study

Immunogenicity and safety of the protein-based heterodimer booster vaccine for COVID-19

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News